BRPI0408209A - new compositions - Google Patents

new compositions

Info

Publication number
BRPI0408209A
BRPI0408209A BRPI0408209-5A BRPI0408209A BRPI0408209A BR PI0408209 A BRPI0408209 A BR PI0408209A BR PI0408209 A BRPI0408209 A BR PI0408209A BR PI0408209 A BRPI0408209 A BR PI0408209A
Authority
BR
Brazil
Prior art keywords
new compositions
formulations
phenthine
relates
present
Prior art date
Application number
BRPI0408209-5A
Other languages
Portuguese (pt)
Inventor
Calvin Ross
Clive Booles
Alistair Campbell
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0305579.5A external-priority patent/GB0305579D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of BRPI0408209A publication Critical patent/BRPI0408209A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"NOVAS COMPOSIçõES". A presente invenção está relacionada a formulações de fentalina, especialmente formulações de borrifamento por bomba adequadas para administração sublingual."NEW COMPOSITIONS". The present invention relates to phenthine formulations, especially pump spray formulations suitable for sublingual administration.

BRPI0408209-5A 2003-03-11 2004-03-11 new compositions BRPI0408209A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl

Publications (1)

Publication Number Publication Date
BRPI0408209A true BRPI0408209A (en) 2006-02-14

Family

ID=32992592

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408209-5A BRPI0408209A (en) 2003-03-11 2004-03-11 new compositions

Country Status (10)

Country Link
EP (1) EP1608372A2 (en)
JP (1) JP2006519770A (en)
KR (1) KR20050115276A (en)
AU (1) AU2004218876B2 (en)
BR (1) BRPI0408209A (en)
CA (1) CA2516338A1 (en)
MX (1) MXPA05009602A (en)
NO (1) NO20054172L (en)
NZ (1) NZ541781A (en)
WO (1) WO2004080382A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767163A1 (en) * 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
SI1976521T1 (en) * 2006-01-25 2015-06-30 Insys Therapeutics, Inc. Sublingual fentanyl spray
WO2009017837A2 (en) 2007-08-02 2009-02-05 Insys Therapeutics Inc. Sublingual fentanyl spray
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19536246A1 (en) * 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmaceutical compsn. for spraying as drops
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
WO1999016417A1 (en) * 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
SE9803239D0 (en) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
AU2879100A (en) * 1999-02-12 2000-08-29 Miles A. Libbey Iii Formulation and system for intra-oral delivery of pharmaceutical agents
AU2001262992A1 (en) * 2000-05-10 2002-02-18 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10064219B9 (en) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Novel pharmaceutical composition containing fentanyl and / or its derivatives

Also Published As

Publication number Publication date
CA2516338A1 (en) 2004-09-23
MXPA05009602A (en) 2005-11-08
KR20050115276A (en) 2005-12-07
EP1608372A2 (en) 2005-12-28
AU2004218876A1 (en) 2004-09-23
WO2004080382A3 (en) 2005-03-24
JP2006519770A (en) 2006-08-31
WO2004080382A2 (en) 2004-09-23
NO20054172L (en) 2005-10-06
NZ541781A (en) 2008-04-30
AU2004218876B2 (en) 2007-08-02
NO20054172D0 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
PL375874A1 (en) 2,6-Diisopropylphenol aqueous pharmaceutical compositions
CR7080A (en) SALES TARTRATO OF 5,8,14-TRIAZATETRACICLO [10.3.1.02,11.04,9] HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
HRP20120323T1 (en) Diarylhydantoin compounds
HN2003000417A (en) INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION UNDERSTANDING A HYGROSCOPIC PHARMACO
BRPI0411916A (en) sulfonamide-substituted imidazoquinolines
DK1300398T3 (en) Propane-1,3-dione derivative
DE60205870D1 (en) ORAL PHARMACEUTICAL COMPOSITION OF CEFPODOXIM PROXETIL
BRPI0408895A (en) Cladribine formulations for improved oral and transmucosal administration
CR9223A (en) 18-METIL-19-NOR-17-PREGN-4-EN-21, 17-CARBOLACTONES, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM
BRPI0509184A (en) pharmaceutical compositions
CR8824A (en) DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
CL2004001120A1 (en) COMPOUNDS DERIVED FROM AMINA REPLACED WITH HETEROCICLES, IMMUNOSUPPRESSORS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT DISEASES MEDIATED BY LYMPHOCYTE INTERACTIONS, SUCH AS AUTOIMMUNE, INFLAMMATORY, INFECTIOUS, CANCER DISEASES.
IS2517B (en) Use of substituted 2-aminotetralins in the prevention of Parkinson's disease
MY143221A (en) Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
BRPI0417950A (en) pharmaceutical compositions
BR0212931A (en) Metformin-containing prolonged release pharmaceutical composition
BR0208813A (en) Imidazotriazinone-containing compositions for nasal application
EA200600590A1 (en) PHARMACEUTICAL COMPOSITIONS OF MODAFINIL WITH MODIFIED DELIVERY
BR0208812A (en) Phenyl heterocyclyl ether derivatives as serotonin reuptake inhibitors
BRPI0412239A (en) emulsifying systems containing azetidine derivatives
BRPI0506779A (en) Ice cream formulation and ice cream
BRPI0408446A (en) cleaning tablet
GT200500358A (en) ORGANIC COMPOUNDS
MXPA06000636A (en) Semi-solid formulations for the oral administration of taxoids.
BRPI0409175A (en) oral pharmaceutical preparation for proton pumping antagonists

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.